Genetically engineered transfusable platelets using mRNA lipid nanoparticles.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
12 2023
Historique:
medline: 4 12 2023
pubmed: 1 12 2023
entrez: 1 12 2023
Statut: ppublish

Résumé

Platelet transfusions are essential for managing bleeding and hemostatic dysfunction and could be expanded as a cell therapy due to the multifunctional role of platelets in various diseases. Creating these cell therapies will require modifying transfusable donor platelets to express therapeutic proteins. However, there are currently no appropriate methods for genetically modifying platelets collected from blood donors. Here, we describe an approach using platelet-optimized lipid nanoparticles containing mRNA (mRNA-LNP) to enable exogenous protein expression in human and rat platelets. Within the library of mRNA-LNP tested, exogenous protein expression did not require nor correlate with platelet activation. Transfected platelets retained hemostatic function and accumulated in regions of vascular damage after transfusion into rats with hemorrhagic shock. We expect this technology will expand the therapeutic potential of platelets.

Identifiants

pubmed: 38039367
doi: 10.1126/sciadv.adi0508
pmc: PMC10691771
doi:

Substances chimiques

Lipid Nanoparticles 0
RNA, Messenger 0
Hemostatics 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadi0508

Subventions

Organisme : U.S. Department of Defense Investigator-Initiated Research Award
ID : W81XWH202004
Organisme : Frederick Banting and Charles Best Doctoral Award
ID : 6552

Références

Transfusion. 2008 Nov;48(11):2331-7
pubmed: 18631169
Mol Ther Nucleic Acids. 2019 Apr 15;15:1-11
pubmed: 30785039
Commun Biol. 2021 Aug 11;4(1):956
pubmed: 34381159
JAMA. 2015 Feb 3;313(5):471-82
pubmed: 25647203
Nat Rev Cardiol. 2019 Mar;16(3):166-179
pubmed: 30429532
Transfusion. 2016 Jan;56(1):13-6
pubmed: 26756706
Sci Rep. 2019 Jan 24;9(1):552
pubmed: 30679556
J Nucl Med. 1985 Jan;26(1):72-6
pubmed: 3965655
Int J Mol Sci. 2022 Jan 20;23(3):
pubmed: 35163024
ACS Chem Biol. 2012 Nov 16;7(11):1848-57
pubmed: 22894855
Transfusion. 1991 Jun;31(5):409-14
pubmed: 1710840
Mol Ther. 2008 Nov;16(11):1833-40
pubmed: 18797453
Blood. 2003 Aug 1;102(3):926-33
pubmed: 12689937
Nat Rev Cancer. 2011 Feb;11(2):123-34
pubmed: 21258396
Nucleic Acid Ther. 2018 Jun;28(3):146-157
pubmed: 29683383
J Control Release. 2019 Feb 10;295:140-152
pubmed: 30610950
J Thromb Haemost. 2020 May;18(5):1183-1196
pubmed: 31997536
Transfusion. 2017 May;57(5):1208-1217
pubmed: 28236302
Nat Nanotechnol. 2020 Apr;15(4):313-320
pubmed: 32251383
J Thromb Haemost. 2009 Feb;7(2):241-6
pubmed: 18983498
J Biol Chem. 2005 May 6;280(18):18025-32
pubmed: 15741160
Mol Pharm. 2022 Jul 4;19(7):2175-2182
pubmed: 35642083
Int J Mol Sci. 2020 Aug 26;21(17):
pubmed: 32858930
Nat Commun. 2013;4:2773
pubmed: 24253479
Nat Biotechnol. 2010 Feb;28(2):172-6
pubmed: 20081866
Res Pract Thromb Haemost. 2022 Dec 20;7(4):100019
pubmed: 37538498
Blood. 2022 Dec 1;140(22):2398-2402
pubmed: 36112961
Vox Sang. 2010 Aug 1;99(2):123-30
pubmed: 20456723
Blood. 2014 Jan 16;123(3):395-403
pubmed: 24269957
Nat Rev Drug Discov. 2018 Apr;17(4):261-279
pubmed: 29326426
Thromb Haemost. 2015 Jul;114(1):96-108
pubmed: 25903651
Clin Lab Med. 2010 Jun;30(2):475-87
pubmed: 20513565
N Engl J Med. 2018 Jul 5;379(1):11-21
pubmed: 29972753
Nat Nanotechnol. 2019 Dec;14(12):1084-1087
pubmed: 31802031
Shock. 2014 May;41 Suppl 1:54-61
pubmed: 24169210
Blood. 2009 Jul 9;114(2):425-36
pubmed: 19332769
Br J Haematol. 2017 Dec;179(5):802-810
pubmed: 29168170
Transfusion. 2021 Jul;61 Suppl 1:S58-S67
pubmed: 34269458
Biochem J. 1995 Mar 1;306 ( Pt 2):337-44
pubmed: 7534064
Transfusion. 2007 Dec;47(12):2260-70
pubmed: 17714413
Crit Rev Clin Lab Sci. 2016 Dec;53(6):409-30
pubmed: 27282765
Transfusion. 2020 Mar;60 Suppl 2:S1-S9
pubmed: 32086817
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Blood Adv. 2022 Dec 13;6(23):6056-6069
pubmed: 36149941
Nanoscale. 2019 May 9;11(18):9023-9031
pubmed: 31021343
Trends Biotechnol. 2021 Jun;39(6):598-612
pubmed: 33160678

Auteurs

Jerry Leung (J)

Michael Smith Laboratories, University of British Columbia, Vancouver, V6T 1Z4, Canada.
Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, V6T 1Z3, Canada.
Centre for Blood Research, University of British Columbia, Vancouver, V6T 1Z3, Canada.
NanoMedicines Research Group, University of British Columbia, Vancouver, V6T 1Z3, Canada.

Colton Strong (C)

Michael Smith Laboratories, University of British Columbia, Vancouver, V6T 1Z4, Canada.
Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, V6T 1Z3, Canada.
Centre for Blood Research, University of British Columbia, Vancouver, V6T 1Z3, Canada.

Katherine E Badior (KE)

Blood Research Institute, Versiti, Milwaukee,WI 53226, USA.

Madelaine Robertson (M)

Michael Smith Laboratories, University of British Columbia, Vancouver, V6T 1Z4, Canada.
Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, V6T 1Z3, Canada.
Centre for Blood Research, University of British Columbia, Vancouver, V6T 1Z3, Canada.
NanoMedicines Research Group, University of British Columbia, Vancouver, V6T 1Z3, Canada.

Xiaowu Wu (X)

Blood and Shock Resuscitation Program, United States Army Institute of Surgical Research, JBSA-FT Sam Houston, San Antonio, TX 78234, USA.

Michael A Meledeo (MA)

Blood and Shock Resuscitation Program, United States Army Institute of Surgical Research, JBSA-FT Sam Houston, San Antonio, TX 78234, USA.

Emma Kang (E)

Centre for Blood Research, University of British Columbia, Vancouver, V6T 1Z3, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 2B5, Canada.

Manoj Paul (M)

Blood Research Institute, Versiti, Milwaukee,WI 53226, USA.

Yusuke Sato (Y)

Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, 060-0812, Japan.

Hideyoshi Harashima (H)

Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, 060-0812, Japan.

Andrew P Cap (AP)

Blood and Shock Resuscitation Program, United States Army Institute of Surgical Research, JBSA-FT Sam Houston, San Antonio, TX 78234, USA.

Dana V Devine (DV)

Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, V6T 1Z3, Canada.
Centre for Blood Research, University of British Columbia, Vancouver, V6T 1Z3, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 2B5, Canada.
Centre for Innovation, Canadian Blood Services, Vancouver, V6T 1Z3, Canada.

Eric Jan (E)

Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, V6T 1Z3, Canada.

Pieter R Cullis (PR)

Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, V6T 1Z3, Canada.
NanoMedicines Research Group, University of British Columbia, Vancouver, V6T 1Z3, Canada.

Christian J Kastrup (CJ)

Michael Smith Laboratories, University of British Columbia, Vancouver, V6T 1Z4, Canada.
Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, V6T 1Z3, Canada.
Centre for Blood Research, University of British Columbia, Vancouver, V6T 1Z3, Canada.
Blood Research Institute, Versiti, Milwaukee,WI 53226, USA.
Departments of Surgery, Biochemistry, Biomedical Engineering, and Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH